Last reviewed · How we verify
Fluzone Quadrivalent vaccine, No Preservative
Fluzone Quadrivalent vaccine, No Preservative is a Biologic drug developed by Sanofi Pasteur, a Sanofi Company. It is currently FDA-approved. Also known as: Fluzone® Quadrivalent Influenza Vaccine.
At a glance
| Generic name | Fluzone Quadrivalent vaccine, No Preservative |
|---|---|
| Also known as | Fluzone® Quadrivalent Influenza Vaccine |
| Sponsor | Sanofi Pasteur, a Sanofi Company |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2020-2021 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively (PHASE4)
- Collection of Serum Samples From Children and Older Adults Receiving the 2019-2020 Formulations of Fluzone® Quadrivalent and Fluzone® High-Dose Influenza Vaccines, Respectively (PHASE4)
- Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively (PHASE4)
- Durability of Vaccine Responses (PHASE4)
- Study of a Single Dose or Two Doses of a Quadrivalent Influenza Vaccine in Subjects Aged 6 Months or Older in India (PHASE3)
- Immunogenicity and Safety of Fluzone® Quadrivalent, Southern Hemisphere 2015 Formulation (Intramuscular Route) (PHASE4)
- Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children (PHASE4)
- Safety and Immunogenicity of Fluzone® Quadrivalent and Fluzone® High-Dose, Influenza Vaccines, 2016-2017 Formulations (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Fluzone Quadrivalent vaccine, No Preservative CI brief — competitive landscape report
- Fluzone Quadrivalent vaccine, No Preservative updates RSS · CI watch RSS
- Sanofi Pasteur, a Sanofi Company portfolio CI
Frequently asked questions about Fluzone Quadrivalent vaccine, No Preservative
What is Fluzone Quadrivalent vaccine, No Preservative?
Fluzone Quadrivalent vaccine, No Preservative is a Biologic drug developed by Sanofi Pasteur, a Sanofi Company.
Who makes Fluzone Quadrivalent vaccine, No Preservative?
Fluzone Quadrivalent vaccine, No Preservative is developed and marketed by Sanofi Pasteur, a Sanofi Company (see full Sanofi Pasteur, a Sanofi Company pipeline at /company/sanofi).
Is Fluzone Quadrivalent vaccine, No Preservative also known as anything else?
Fluzone Quadrivalent vaccine, No Preservative is also known as Fluzone® Quadrivalent Influenza Vaccine.
What development phase is Fluzone Quadrivalent vaccine, No Preservative in?
Fluzone Quadrivalent vaccine, No Preservative is FDA-approved (marketed).
Related
- Manufacturer: Sanofi Pasteur, a Sanofi Company — full pipeline
- Also known as: Fluzone® Quadrivalent Influenza Vaccine
- Compare: Fluzone Quadrivalent vaccine, No Preservative vs similar drugs
- Pricing: Fluzone Quadrivalent vaccine, No Preservative cost, discount & access